Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in

Shiji Zhou1, Shengwei Li, Zuojin Liu

  • 1Department of Hepatobiliary Surgery, Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing 400010, PR China.

Abstract

Insights

Ultrasound-targeted microbubble destruction effectively delivers the herpes simplex virus thymidine kinase (HSV-TK) gene to tumors. This method significantly inhibits hepatoma growth and improves survival time in mice.

Area of Science:

  • Oncology
  • Gene Therapy
  • Medical Imaging

Background:

  • Hepatoma poses a significant global health challenge.
  • Gene therapy offers a promising avenue for cancer treatment.
  • Targeted delivery systems are crucial for enhancing gene therapy efficacy.

Purpose of the Study:

  • To investigate the anti-tumor effects of a novel gene therapy approach.
  • To evaluate ultrasound-targeted microbubble destruction for delivering the herpes simplex virus thymidine kinase (HSV-TK) suicide gene system.
  • To assess the efficacy of this system in a murine hepatoma model.

Main Methods:

  • Establishment of subcutaneous hepatoma models in 40 mice.
  • Random assignment into four groups: PBS, HSV-TK, HSV-TK+Ultrasound (US), and HSV-TK+US+Microbubbles (MB).
  • Assessment of TK protein expression (Western blot), tumor cell apoptosis (TUNEL staining), tumor inhibition rates, and survival time.

Main Results:

  • Significantly higher TK protein expression in the HSV-TK+US+MB group compared to other groups.
  • Ultrasound-targeted microbubble destruction mediated HSV-TK demonstrated superior tumor inhibition in transplantable tumors (p < 0.05).
  • This approach significantly improved the survival time of tumor-bearing mice.

Conclusions:

  • Ultrasound-targeted microbubble destruction is an effective method for transfecting the HSV-TK gene into target tissues.
  • This system exhibits a significant tumor inhibition effect on hepatoma.
  • This strategy provides a novel approach for gene therapy in liver cancer treatment.

Related Concept Videos